Tongjitang files going-private statement on Schedule 13E-3 with SEC

Tongjitang Chinese Medicines Company ("Tongjitang" or the "Company") (NYSE: TCM), a leading specialty pharmaceutical company focusing on the development, manufacturing, marketing and selling of modernized traditional Chinese medicine in China, today announced that it has filed a going-private transaction statement on Schedule 13E-3 ("Going-Private Statement") with the United States Securities and Exchange Commission ("SEC"). Attached as an exhibit to the Going-Private Statement is a preliminary proxy statement (the "Preliminary Proxy Statement") to be used in connection with an extraordinary general meeting of shareholders (the "EGM") which Tongjitang expects to hold on or about February 28, 2011, subject to obtaining required regulatory approvals prior to such date.

As described more fully in the Going-Private Statement and the Preliminary Proxy Statement, the business to be transacted at the EGM includes shareholder approval of the proposed merger and the agreement and plan of merger, dated as of October 29, 2010, by and among Fosun Industrial Co., Limited, Hanmax Investment Limited, Tonsun International Company Limited, and the Company (the "Merger Agreement"). The proposed merger and the Merger Agreement are more fully described in the Going-Private Statement and the exhibits attached thereto, including the Preliminary Proxy Statement. In addition, a copy of the Merger Agreement is attached as an exhibit to the Preliminary Proxy Statement. The Company's shareholders and ADS holders are urged to review the Going-Private Statement and all of the exhibits thereto, including the Preliminary Proxy Statement and the Merger Agreement, for more information regarding the proposed merger and the Merger Agreement.

Source:

Tongjitang Chinese Medicines Company

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Step up your cosmetics manufacturing with OHAUS!